Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy. (Q46822230)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 October 2012

Language	Label	Description	Also known as
English	Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy.	scientific article published on 29 October 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

11

object named as

Chien Jen Chen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Chin Hao Chang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yu Min Yeh

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Gee Chen Chang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Ying Huang Tsai

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yuh Min Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Ming Shyan Huang

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Hui Ling Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yao Jen Li

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Pan Chyr Yang

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Chao A Hsiung

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

0 references

publication date

29 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

132

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1977-1985

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

A five-gene signature and clinical outcome in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Mining the plasma proteome for cancer biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Interleukin-6 and its receptor: from bench to bedside

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Serum levels of interleukin 6 in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Cisplatin treatment induces a transient increase in tumorigenic potential associated with high interleukin-6 expression in head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

IL-6 involvement in epithelial cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Interaction between smoking and the interleukin-6 gene affects systemic levels of inflammatory biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Sex differences in monocyte expression of IL-6: role of autonomic mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

DNA damage-mediated induction of a chemoresistant niche

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Multiplex serum biomarker assessments: technical and biostatistical issues

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Pitfalls in retrospective analyses of biomarkers: a case study with metastatic melanoma patients.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27892

21 January 2018

Identifiers

10.1002/IJC.27892

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034889%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46822230&oldid=2229101148"